">
Tuesday, 19 May 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 19 May 2026
News

Wait time blows out to 3.6 years

Posted 19 May 2026 AM 

Australia’s wait-time for access to innovative medicines has blown out to an average of 3.6 years, with Medicines Australia (MA) warning that ballooning “bureaucratic delays” is leading some drug makers to abandon the jurisdiction all together.

In the newly released Access Denied report, MA exposes a ‘chilling effect’ on local access to groundbreaking new medicines with a survey finding 84 per cent of pharmaceutical companies say Australia is becoming a lower priority launch market.

To see the whole article, please login

Popular

Aussie GM steps up to regional role
Pharma flags 4500 job cuts
AZ scrambles to shift $17M market
Health PR agency snaps up Award
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home